Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus ropivacaine TAP block for postoperative analgesia in inguinal hernia repair
ChiCTR1800014641Phase 4Not yet recruiting
- Sponsor
- Xuzhou Cancer Hospital
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and ropivacaine in inguinal hernia (2 arms), sponsored by Xuzhou Cancer Hospital. Primary endpoints: Operation time, Recovery time and 6 more. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on ChiCTR1800014641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014641.